Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
about
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patientsBlood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysisPrognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-AnalysisTargeting inflammation in pancreatic cancer: Clinical translationIndications for staging laparoscopy in pancreatic cancerInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsPrognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma.Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisEvaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsNeutrophil to lymphocyte ratio predicts persistent organ failure and in-hospital mortality in an Asian Chinese population of acute pancreatitis.Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.Patterns of acute inflammatory symptoms prior to cancer diagnosis.Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.Evaluation of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Red Blood Cell Distribution Width-Platelet Ratio for Diagnosis of Premature Ovarian Insufficiency.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Prognostic value of PLR in various cancers: a meta-analysis.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisPrognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapyPreoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancerPeritonitis incidence was correlated with duration of peritoneal dialysis rather than leptin or neutrophil to lymphocyte (n/l) ratio in peritoneal dialysis patients.Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiationExternal validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.Evaluation of the association of sleep apnea-related systemic inflammation with CRP, ESR, and neutrophil-to-lymphocyte ratio.The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study.Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic reviewPrognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysisPhase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation.Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma.More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic ActivityPrognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancerSurvival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.
P2860
Q24568136-058CA534-C5BE-47A1-8EBA-FE564F18F4CDQ24658602-DFB52AC1-D301-4CC9-A3D1-18B390ADD64BQ26751553-0B6F3B8F-2790-441B-8070-4A8378BC5AB1Q26751686-7DE77B8F-99B7-4A2C-9A83-DF470DD6CFC8Q26771578-738A2D43-7161-47C5-8A77-75A47D46F2A6Q27009534-4013829A-CF98-4C11-97CC-E6EB300D6AF3Q27332109-3F629104-4845-4184-BD70-563080BD4E8AQ28083684-E82BF167-3453-4377-97D6-5B6FBE9D73FFQ28542043-97980119-9204-48EA-A1AA-98AD491D8756Q33595219-D5CCD30C-F7AD-43C3-BC1D-BD66B32AB721Q33598412-8FF6A353-936F-42C3-8C6D-E7732D40E7D2Q33613637-1ADA8762-5774-4E45-B796-ADCDA2FF6116Q33624392-A0E1682F-653E-45B4-8DBB-136CB742FCC0Q33669405-46D2746B-1FED-4CA7-BF31-18F3AC997BA5Q33677891-3F732AD1-D598-4FE7-BD55-FA5065906DEAQ33716354-DAE60985-95F3-4C49-B8C6-F54FA60797BAQ33762053-2633DB62-4731-4649-BF93-42D34564E174Q33812584-0BDE0E33-D1C0-4137-8E2A-155086CBCF12Q33829684-0CCA1FCB-56DD-4059-B2D1-0F7C7727BB9BQ33884484-F686CFCF-2BB6-4D64-AAD5-7A065B12269DQ33912315-BD08B939-8502-444D-94CB-8A78515075FEQ33994372-007EA13F-4636-4CEB-9EC1-81AED028AC58Q34337667-D8320971-226C-4BA7-B758-DF8656771789Q34987986-0FBD7252-5F87-4B04-B3D3-BC891CA1B95CQ34989484-DA9553F0-BCE7-4D22-AE52-D9E4DB5D248DQ35040836-55D5DCA5-3717-40ED-9F55-7E6CBEB49F20Q35105057-0DFA2FA0-017A-4052-A7AF-3B7DD34899DAQ35131890-B68A1624-827C-43C2-80F5-4AA7A7C14CE2Q35149685-9D8E4F7A-16BC-4328-AA2F-2070FBBD6155Q35202177-D942CFBA-584F-4EF0-87ED-42114DD93E8FQ35424504-ECBD36E7-6240-4CB3-8FCA-C3F896CE2900Q35538449-059C9911-C894-4A5B-97A4-B479FE2F9BC9Q35565212-7ABA976B-FE5A-48FF-9FB1-A16EF08A1E68Q35594253-F8E71E18-DCD6-41B8-B3DE-427A5C6B9139Q35858209-84F5AD96-D97F-4B4F-8DCB-640B85F36F46Q35884149-70538763-E378-4AC8-B95C-A0CEE991240AQ35905788-EC61B754-23E3-4105-AC61-1045FC404B5EQ35925423-3CE06BC5-040C-48F1-999A-6F9730E18F00Q35956259-6F1B602B-E953-4AB3-B21E-B98DAE3E9236Q36019935-D551ECDB-8C49-40D0-8716-3C68C9722F41
P2860
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@en
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@nl
type
label
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@en
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@nl
prefLabel
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@en
Increased neutrophil-lymphocyt ...... inoperable pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Increased neutrophil-lymphocyt ...... d inoperable pancreatic cancer
@en
P2093
F S Seggewies
H Samonigg
J Szkandera
P2860
P2888
P304
P356
10.1038/BJC.2013.332
P407
P577
2013-06-25T00:00:00Z